Publications
- IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis2022 | Second Faculty of Medicine
- Pegylated inteferon beta 1-a in clinical routine2019 | Second Faculty of Medicine
- MxA mRNA decrease preceding NAb detection in IFN beta-treated MS patients2017 | First Faculty of Medicine, Second Faculty of Medicine
- Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFN beta2017 | First Faculty of Medicine, Second Faculty of Medicine
- Myxovirus resistance protein A in interferon-β therapy in patients with multiple sclerosis and treatment effectiveness monitoring algorithm2016 | First Faculty of Medicine, Second Faculty of Medicine
- Interpretation of neutralizing antibodies and myxovirus resitance protein A testing in patients with multiple sclerosis treated with interferon beta2014 | Second Faculty of Medicine
- Monitoring of the Biological Effect of Interferon Beta in the Treatment of Multiple Sclerosis2013 | Second Faculty of Medicine
- Monitoring of interferon beta bioactivity in the multiple sclerosis2011 | Second Faculty of Medicine
- Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis2010 | Second Faculty of Medicine
- Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
Loading network view...